Skip to main content
Caplight Logo









Demetrix

Demetrix

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://demetrix.com

Last Round

Series A

Jul 11, 2019

Total Funding Raised

$61M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Demetrix is a biotechnology company that developed a fermentation system to produce natural medicines and rare cannabinoids through genetics and computing-enabled technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Data as a Service

AI Layer

Non-AI

Keywords

rare cannabinoidsyeast fermentationsynthetic biologybiomanufacturingprecision fermentationcannabinoid productioncontract manufacturingCMObio-based ingredientsCPG ingredientslab-grown cannabinoidsfermentation platformsustainable ingredientsB2B biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Demetrix Comparables

Compare Demetrix with similar companies based on industry and business-model similarity.

Demetrix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Creo
90%
Hyasynth Biologicals Inc.
90%
Biomedican
87%

Demetrix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 11, 2019
SeedSep 6, 2017

Demetrix Investors

Notable investors and investment history

Demetrix investors
InvestorRounds
Horizons VenturesSeries A, Seed
Tuatara CapitalSeries A
Berkeley Catalyst FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 202% MoM.

  • Jul 11, 2019

    $50M round led by Tuatara Capital

Demetrix Filings

Explore SEC and related filing metadata, where available.

Demetrix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Demetrix's valuation, stock price, and market status.

Is Demetrix a public or private company?

Demetrix is a private company.

What is the current stock price of Demetrix?

Demetrix is a private company with no public stock price. No recent secondary market data is available.

How much is Demetrix worth (valuation)?

Valuation information for Demetrix is not publicly available.

Can I buy Demetrix stock?

Demetrix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Demetrix's last funding round?

Demetrix's most recent funding round was Series A on July 11, 2019.

Who are the main investors in Demetrix?

Key investors in Demetrix include Horizons Ventures, Tuatara Capital.

Will Demetrix IPO soon?

No public IPO plans have been announced for Demetrix.

How can I track Demetrix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Demetrix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range20
Year Founded2015
Last FundingJul 11, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?